Please Distribute
The Society for Clinical Trials is issuing a call for papers for its new
journal, published through Arnold Journals, UK, whose first issue will be
published in January, 2004:
CLINICAL TRIALS: JOURNAL OF THE SOCIETY FOR CLINICAL TRIALS
EDITOR: Steven Goodman, MD, MHS, PhD
Johns Hopkins University
Schools of Medicine
and Public Health
[log in to unmask]
Advisory Board:
Dave DeMets, Janet Wittes, Bob Temple, Iain Chalmers, David Sackett, Julie
Buring, Don Berry, and Janet Darbyshire.
Editorial Board:
Doug Altman, Abdel Babiker, Hilda Bastian, Colin Begg, Jesse Berlin, Baruch
Brody, Marc Buyse, Rob Califf, Mike Clarke, Steve Cole, Jeff Cutler, Kay
Dickersin, Matthias Egger, Diana Elbourne, Susan Ellenberg, Diane
Fairclough, Dianne Finkelstein, Nancy Geller, Stephanie Green, Catherine
Hill, John Ioannidis, Alejandro Jadad, Ted Karrison, Richard Lilford, Phil
Lavori, Tom Louis, Harry Marks, Steve Piantadosi, Ron Prineas, David
Schoenfeld, Steven Self, Joe Shih, Jay Siegel, Steve Snappin, Jeremy
Sugarman, and Peter Thall.
To submit papers to CLINICAL TRIALS, please submit an electronic file (PDF
or MS Word compatible) with cover letter and full manuscript to
[log in to unmask], or email the Editor at [log in to unmask]
The Clinical Trials journal website will be at: www.sctjournal.com
Information about the Society for Clinical Trials can be found at:
www.sctweb.org
DESCRIPTION, AIMS and SCOPE
CLINICAL TRIALS: Journal of the Society for Clinical Trials is an
international journal that aims to be a primary focus for the dissemination
and development of knowledge about the design, conduct, analysis, reporting,
ethics, synthesis, regulation, history and impact of all types of clinical
trials and related health care research methodologies. Articles should be of
interest to audiences in the many disciplines and specialties in the health
professions, the sciences, humanities, legal and policy communities involved
in or concerned with conduct or outcomes of clinical trials. The journal
will be published in 6 issues per year and prepublication papers will be
available online. The first issue will be published in Jan/Feb 2004.
Full-length papers (original research and commentaries, 2500-5000 words) and
short communications (up to 1,500 words) will be published.
The following list is illustrative of the aims and scope of the
journal; other topics may be suitable.
Statistical methods
Statistical methods for analyzing and designing all types of clinical
trials, Phase I-IV.
Methods to handle departures from randomization
Quality of life assessment
Methods for handling missing data
Sample size calculations for specific design features
Methods for subgroup analysis
Methods for meta-analysis
Methods for data-monitoring
Design and conduct
Interesting design features of specific trials
Organizational aspects of multicenter investigations
Data and safety monitoring
Assessing patient adherence
Design of case report forms and other data collection methods.
Methods for collecting and reporting adverse event data
Procedures for maintaining databases.
Informatics
Quality assurance procedures
Data auditing
Special issues for trials in developing countries
Impact
The impact of clinical trials on the practice of medicine and health care
delivery
Impact of clinical trials on subsequent research
Role of clinical trials in health policy
Differential regional impact, particularly in developing countries.
Trial identification
Publication bias
Trial registries
Issues related to non-English publication
Ethics
Empirical ethics research
Informed consent
Ethics of international or trans-cultural clinical trials
Ethics of recruitment
Law and regulation
Harmonization
Issues in drug or device development
Synthesis and evidence evaluation
Assessment of the quality of clinical trials
Comparisons of clinical trials and alternative research methodologies
Methodology of evidence synthesis, meta-analysis, systematic reviews
Issues related to the reporting or peer review of clinical trials
History
Historical reviews of important trials or syntheses
Interviews with senior investigators of landmark trials
Education and training
Methods for education and training in clinical trial methods
Tutorials on any methods related to clinical trial conduct or analysis
Patient-related issues
Patient involvement in the design or monitoring of clinical trials
Assessing patient preferences
Communicating clinical trial results to patients and lay audiences
Working with and educating advocacy groups about clinical trials
Representation of subgroups in clinical trials
Health Economics
Cost-benefit analyses as they relate to trials, including the cost of trials
Use of economic outcomes in clinical trials
The use of trial or meta-analytic results in health economic analyses
Miscellany
Commentaries/perspectives on recent debates or issues in clinical trials
Proceedings of meetings or conferences on clinical trials issues
|